Aymane, Khouya
Alina, Santiago
Toke, Ringbaek
Nika, Guberina
Maja, Guberina
Thomas, Gauler
Wolfgang, Lübcke
Waldemar, Zylka
Christoph, Pöttgen
Martin, Stuschke
Article History
Received: 10 March 2025
Accepted: 1 May 2025
First Online: 15 May 2025
Declarations
:
: The study was approved by the Ethics Committee of the Medical Faculty of the University of Duisburg-Essen. All treated patients gave their consent to the treatment taking part in the prospective, institutional clinical registry trial No. 18-8364-BO Date of registration: 13.03.2019 and was registered at clinicalTrials.gov National Center for Tumor Diseases (NCT) No. (NCT06222190), trial Registration Date: 15.01.2024. The study was conducted in accordance with the principles of the Declaration of Helsinki.
: Informed consents was obtained from all subjects involved in the study.
: The authors declare no competing interests.